Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhijiang Huayi Pharmaceutical is a pharmaceutical manufacturing enterprise located in Zhijiang, Hubei Province, China. The company specializes in the production of Active Pharmaceutical Ingredients (APIs) and chemical intermediates, with a strong focus on metabolic diseases. Its core product portfolio includes widely used anti-diabetic agents such as Metformin Hydrochloride and Gliclazide. Zhijiang Huayi maintains GMP-compliant facilities to ensure high-quality standards for domestic and global distribution. The company serves as a critical supplier in the pharmaceutical value chain, providing essential raw materials for finished dosage form manufacturers. It also engages in the development of chemical synthesis processes to optimize production efficiency and product purity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhijiang Huayi Pharmaceutical.